Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Strategy for prevention of cancers of the esophagus 12th OESO World Conference - Cancers of the Esophagus Akiyama, J., Alexandre, L., Baruah, A., Buttar, N., Chandra, R., Clark, A. B., Hart, A. R., Hawk, E., Kandioler, D., Kappel, S., Krishnadath, S. K., Sharma, A., Singh, I., Straub, D., Triadafilopoulos, G., Umar, A., Wolf, B. BLACKWELL SCIENCE PUBL. 2014: 108–126

Abstract

The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the animal reflux-inflammation models for Barrett's esophagus and esophageal adenocarcinoma; genomic/epigenomic analyses; eflornithine-based combinations; the molecular derangements that promote neoplastic transformation; the role of COX-2 inhibitors, proton pump inhibitors, and phase II trials in Barrett's adenocarcinoma; statins in chemoprevention and treatment of esophageal cancer; and biomarkers as potential targets in Barrett's adenocarcinoma.

View details for DOI 10.1111/nyas.12529

View details for Web of Science ID 000343712700013

View details for PubMedID 25266020